Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × selinexor × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 13 Recurrence 4 Sarcoma 2 Glioblastoma 2 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Smooth Muscle Tumor 1 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Salivary Gland Neoplasms 1 Primary Myelofibrosis 1 Osteosarcoma 1 Neurofibrosarcoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Adipose Tissue 1 Neoplasms 1 Neoplasm Metastasis 1 Myoepithelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Hodgkin Disease 1 Histiocytoma, Angiomatoid Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 Granuloma, Plasma Cell 1

Interventions

pembrolizumab 11 Cisplatin 9 Carboplatin 9 Paclitaxel 6 Radiotherapy, Intensity-Modulated 5 Radiotherapy 4 cemiplimab 3 Radiation 3 Docetaxel 3 Blood Specimen Collection 3 alpha-2'-deoxythioguanosine 2 Taxes 2 Standard of Care 2 Nivolumab 2 Drug Therapy 2 toripalimab 1 regorafenib 1 olaparib 1 lenvatinib 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 bavituximab 1 avelumab 1 atezolizumab 1 aldesleukin 1 aflibercept 1 Vitamin D 1 Vinorelbine 1 Tumor Burden 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡